Neurochemical correlates of autistic disorder: A review of the literature

Aman, 1999, Review of serotonergic agents and perseverative behavior in patients with developmental disabilities, Mental Retardation and Developmental Disabilities Research Reviews, 5, 279, 10.1002/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO;2-6 Aman, 1989, Review of fenfluramine in the treatment of the developmental disabilities, Journal of the American Academy of Child and Adolescent Psychiatry, 28, 549, 10.1097/00004583-198907000-00014 Aman, 2003, Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio, Journal of Autism and Developmental Disorders, 33, 527, 10.1023/A:1025883612879 Aman, 2000, Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders, Journal of Autism and Developmental Disorders, 30, 451, 10.1023/A:1005559725475 Aman, 1994 Aman, 1985, The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects, American Journal of Mental Deficiency, 89, 485 Amaral, 1977, The locus coeruleus: neurobiology of a central noradrenergic nucleus, Progress in Neurobiology, 9, 147, 10.1016/0301-0082(77)90016-8 American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association. Anderson, 1994, Studies on the neurochemistry in autism, 227 Anderson, 1987, Whole blood serotonin in autistic and normal subjects, Journal of Child Psychology and Psychiatry, 28, 885, 10.1111/j.1469-7610.1987.tb00677.x Anderson, 1997, Neurochemical studies of autism, 325 Angold, 1999, Comorbidity, Journal of Child Psychology and Psychiatry and Allied Disciplines, 40, 57, 10.1111/1469-7610.00424 Bailey, 1995, Autism as a strongly genetic disorder: evidence from a British twin study, Psychological Medicine, 25, 63, 10.1017/S0033291700028099 Barberis, 1996, Vasopressin and oxytocin receptors in the central nervous system, Critical Reviews in Neurobiology, 10, 119, 10.1615/CritRevNeurobiol.v10.i1.60 Barthelemy, 1988, Urinary free and conjugated catecholamine and metabolites in autistic children, Journal of Autism and Developmental Disorders, 18, 585, 10.1007/BF02211876 Bauman, 1994, Neuroanatomic observations of the brain in autism, 119 Belendiuk, 1980, Blood monoamine levels in Huntington's disease, Archives of General Psychiatry, 37, 325, 10.1001/archpsyc.1980.01780160095011 Belsito, 2001, Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial, Journal of Autism and Developmental Disorders, 31, 175, 10.1023/A:1010799115457 Bittigau, 1997, Glutamate in neurologic diseases, Journal of Child Neurology, 12, 471, 10.1177/088307389701200802 Bolton, 1994, A case-controlled family history study of autism, Journal of Child and Adolescent Psychiatry, 35, 877 Bouvard, 1995, Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study, Psychiatry Research, 58, 191, 10.1016/0165-1781(95)02601-R Brambilla, 1969, Endocrine aspects of child psychoses, Diseases of the Nervous System, 30, 627 Bristol, 1996, State of the science in autism: report to the National Institutes of Health, Journal of Autism and Developmental Disorders, 26, 121, 10.1007/BF02172002 Butterweck, 2001, St. John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats, Molecular Psychiatry, 6, 547, 10.1038/sj.mp.4000937 Calne, 1975, Dopaminergic mechanisms Campbell, 1993, Naltrexone in autistic children: Behavioral symptoms and attentional learning, Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1263 Campbell, 1990, Pharmacotherapy in autism, Brain Dysfunction, 3, 299 Campbell, 1975, Blood serotonin in schizophrenic children: A preliminary study, International Pharmacopsychiatry, 10, 213, 10.1159/000468197 Campbell, 1989, Naltrexone in autistic children: an acute open dose range tolerance trial, Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200, 10.1097/00004583-198903000-00009 Campbell, 1980, Some physical parameters of young autistic children, Journal of the American Academy of Child and Adolescent Psychiatry, 19, 193, 10.1016/S0002-7138(09)60697-X Carlson, N. R. (2001). Physiology of behavior (7th ed., pp. 96–129). Boston: Allyn and Bacon. Chakrabarti, 2001, Pervasive developmental disorders in preschool children, Journal of the American Medical Association, 285, 3093, 10.1001/jama.285.24.3093 Chamberlain, 1990, A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism, Biological Psychiatry, 28, 773, 10.1016/0006-3223(90)90513-2 Chez, 2004, Treating autistic spectrum disorders in children: Utility of the cholinesterase inhibitor rivastigmine tartrate, Journal of Child Neurology, 19, 165 Chez, M. G., Tremb, R. J., Nowinski, C. V., & Field-Chez, M. (2001). Double-blinded placebo-controlled Aricept study in children with autism spectrum disorder. In Proceedings of the Abstract presented at: 30th Annual Meeting of the Child Neurology Society, 17–20 October, Victoria, BC, Canada. Chugani, 1997, Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys, Annals of Neurology, 14, 666, 10.1002/ana.410420420 Chugani, 1999, Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Annals of Neurology, 45, 287, 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9 Cohen, 1974, Biogenic amines in autistic and atypical children: Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid, Archives of General Psychiatry, 31, 845, 10.1001/archpsyc.1974.01760180085011 Cohen, 1977, Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid, Archives of General Psychiatry, 34, 545, 10.1001/archpsyc.1977.01770170055004 Cook, 1990, Autism: Review of neurochemical investigation, Synapse, 6, 292, 10.1002/syn.890060309 Cook, 1997, Evidence of linkage between the serotonin transporter and autistic disorder, Molecular Psychiatry, 2, 247, 10.1038/sj.mp.4000266 Cook, 1988, Free serotonin in plasma: Autistic children and their first-degree relatives, Biological Psychiatry, 24, 488, 10.1016/0006-3223(88)90192-8 Cook, 1990, Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence, Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268, 10.1176/jnp.2.3.268 Cook, 1992, Fluvoxetine treatment of children and adults with autistic disorder and mental retardation, Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739, 10.1097/00004583-199207000-00024 Costa, 1977, Nonstriatal dopaminergic neurons Croonenberghs, 2000, Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder, Neuropsychopharmacology, 22, 275, 10.1016/S0893-133X(99)00131-1 Cuccaro, 1993, Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives, Journal of Neuropsychiatry and Clinical Neurosciences, 5, 94, 10.1176/jnp.5.1.94 Davis, 1992, Autism and developmental abnormalities in children with perinatal cocaine exposure, Journal of the National Medical Association, 84, 315 Elchiasak, 1978, Contribution of plasma homovanillic acid (HVA) to urine and CSF HVA in the monkey and its pharmacokinetic dispostion, Life Sciences, 23, 2339, 10.1016/0024-3205(78)90200-X Ernst, 1993, Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children, Psychopharmacology Bulletin, 29, 221 Ernst, 1999, Antipsychotics (Neuroleptics), 297 Fatemi, 2002, Glutamic acid decarboxylase 65 & 67kDa proteins are reduced in autistic parietal & cerebellar cortices, Biological Psychiatry, 52, 805, 10.1016/S0006-3223(02)01430-0 Fraser, 1998, Beta-adrenergic blockers, 271 Freedman, 1981, Blood tryptophan metabolism in chronic schizophrenics, Archives of General Psychiatry, 38, 655, 10.1001/archpsyc.1981.01780310055005 Gillberg, 1993, Not less likely than before that mean CSF HVA may be high in autism, Biological Psychiatry, 34, 746, 10.1016/0006-3223(93)90047-H Gillberg, 1992 Gillberg, 1990, CSF beta-endorphin in childhood neuropsychiatric disorders, Brain and Development, 12, 88, 10.1016/S0387-7604(12)80185-9 Gillberg, 1983, Childhood psychosis and monoamine metabolites in spinal fluid, Journal of Autism and Developmental Disorders, 13, 383, 10.1007/BF01531587 Gillberg, 1987, CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood, British Journal of Psychiatry, 151, 89, 10.1192/bjp.151.1.89 Goodwin, 1971, Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children, Journal of Autism and Childhood Schizophrenia, 1, 148, 10.1007/BF01537742 Gordon, 1993, A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder, Archives of General Psychiatry, 50, 441, 10.1001/archpsyc.1993.01820180039004 Gwirtsman, 1982, The overnight dexamethasone suppression test: Clinical and theoretical review, Journal of Clinical Psychiatry, 43, 321 Hanley, 1977, Hyperserotonemia and amine metabolites in autistic and retarded children, Archives of General Psychiatry, 34, 521, 10.1001/archpsyc.1977.01770170031002 Hardan, 2002, A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder, Journal of Child and Adolescent Psychopharmacology, 12, 237, 10.1089/104454602760386923 Herman, 1986, Effects of naltrexone in autism: correlation with plasma opioid concentrations, 11 Hill, 1977, Diurnal cortisol and temperature variation of normal and autistic children, Developmental Psychobiology, 10, 579, 10.1002/dev.420100612 Hollander, 2001, An open trial of divalproex sodium in autistic spectrum disorders, Journal of Clinical Psychiatry, 62, 530, 10.4088/JCP.v62n07a05 Hollander, 2003, Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders, Neuropsychopharmacology, 28, 193, 10.1038/sj.npp.1300021 Hoshino, 1987, The diurnal variation and response to dexamethasone suppression test of saliva cortisol levels of autistic children, Japanese Journal of Psychiatry and Neurology, 41, 227 Hussman, 2001, Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism, Journal of Autism and Developmental Disorders, 31, 247, 10.1023/A:1010715619091 Insel, 1992, Oxytocin: a neuropeptide for affiliation B evidence form behavioral, receptor autoradiographic, and comparative studies, Psychoneuroendocrinology, 17, 3, 10.1016/0306-4530(92)90073-G Insel, 1995, A gender specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles, Behavioral Neuroscience, 109, 782, 10.1037/0735-7044.109.4.782 Insel, 1999, Oxytocin, vasopressin, and autism: is there a connection?, Biological Psychiatry, 45, 145, 10.1016/S0006-3223(98)00142-5 Jensen, 1985, The dexamethasone suppression test in infantile autism, Journal of the American Academy of Child and Adolescent Psychiatry, 24, 263, 10.1016/S0002-7138(09)61085-2 Jorde, 1990, The UCLA-University of Utah epidemiologic survey of autism: Genealogical analysis of familial aggregation, American Journal of Medical Genetics, 36, 85, 10.1002/ajmg.1320360116 Kalat, 1978, Letter to the editor: Speculations on similarities between autism and opiate addiction, Journal of Autism and Childhood Schizophrenia, 8, 477, 10.1007/BF01538051 Kandel, 1995 King, 2001, Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder, Journal of the American Academy of Child and Adolescent Psychiatry, 40, 658, 10.1097/00004583-200106000-00010 Klauck, 1997, Serotonin transporter (5-HTT) gene variants associated with autism?, Human Molecular Genetics, 6, 2233, 10.1093/hmg/6.13.2233 Kornhuber, 1989, Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: Transient elevation during early childhood, Life Science, 45, 745, 10.1016/0024-3205(89)90094-5 Kramer, 1994, In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse, Brain Research Developmental Brain Research, 78, 142, 10.1016/0165-3806(94)90019-1 Lake, 1977, Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism, Archives in General Psychiatry, 34, 553, 10.1001/archpsyc.1977.01770170063005 Langworthy-Lam, 2002, Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina, Journal of Child and Adolescent Psychopharmacology, 12, 311, 10.1089/104454602762599853 Launay, 1987, Catecholamine metabolism in infantile autism: a controlled study of 22 autistic children, Journal of Autism and Developmental Disorders, 17, 333, 10.1007/BF01487064 Leboyer, 1992, A double-blind study of naltrexone in infantile autism, Journal of Autism and Developmental Disorders, 17, 333 Leboyer, 1994, Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism, American Journal of Psychiatry, 151, 1797, 10.1176/ajp.151.12.1797 Leckman, 1980, CSF monoamine metabolites in child and adult psychiatric patients’. A developmental perspective, Archives of General Psychiatry, 37, 677, 10.1001/archpsyc.1980.01780190075009 Lee, 2002, Nicotinic receptor abnormalities in the cerebellar cortex in autism, Brain, 125, 1483, 10.1093/brain/awf160 Lesch, 1993, Primary structure of the human platelet serotonin (5-HT) uptake site: Identity with the brain 5-HT transporter, Journal of Neurochemistry, 60, 2319, 10.1111/j.1471-4159.1993.tb03522.x Leventhal, 1990, Relationships of whole blood serotonin and plasma norepinephrine within families, Journal of Autism and Developmental Disorders, 22, 309 Lord, 1995, Follow-up of two-year-olds referred for possible autism, Journal of Child Psychology and Psychiatry, 36, 1365, 10.1111/j.1469-7610.1995.tb01669.x Lord, 1994, Autism Diagnostic Interview—Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders, Journal of Autism and Developmental Disorders, 24, 659, 10.1007/BF02172145 Maas, 1980, Estimates of dopamine and serotonin synthesis by the awake human brain, Journal of Neurochemistry, 34, 1547, 10.1111/j.1471-4159.1980.tb11240.x Maccari, 1992, Noradrenergic regulation of type-I and type-II corticosteroid receptors in amygdala and hypothalamus, Brain Research, 587, 313, 10.1016/0006-8993(92)91013-5 Maestrini, 1999, Serotonin transporter (5-HTTT) and gamma-aminobutyric acid receptor subunit beta-three (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families, American Journal of Medical Genetics, 88, 492, 10.1002/(SICI)1096-8628(19991015)88:5<492::AID-AJMG11>3.0.CO;2-X Maher, 1975, Peculiarities in the endocrine response to insulin stress in early infantile autism, Journal of Nervous and Mental Disorders, 161, 180, 10.1097/00005053-197509000-00005 Marrosu, 1987, Paradoxical reactions elicited by diazepam in children with classic autism, Functional Neurology, 3, 355 Marsden, 1981, Effect of l-tryptophan on mouse brain 5-hydroxytryptamine: comparison of values obtained using a fluorimetric assay and a liquid chromatographic assay with electrochemical detection, Journal of Neurochemistry, 36, 1621, 10.1111/j.1471-4159.1981.tb00411.x Martin-Ruiz, 2004, Molecular analysis of nicotinic receptor expression in autism, Molecular Brain Research, 123, 81, 10.1016/j.molbrainres.2004.01.003 Martineau, 1992, Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects, Developmental Medicine and Child Neurology, 34, 593, 10.1111/j.1469-8749.1992.tb11490.x McBride, 1998, Effects of diagnosis, race, and puberty of platelet serotonin levels in autism and mental retardation, Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767, 10.1097/00004583-199807000-00017 McDougle, 1996, Effects of tryptophan depletion in drug-free adults with autistic disorder, Archives of General Psychiatry, 53, 993, 10.1001/archpsyc.1996.01830110029004 McDougle, 1996, A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder, Archives of General Psychiatry, 53, 1001, 10.1001/archpsyc.1996.01830110037005 McDougle, 2003, Autistic and other pervasive developmental disorders, 563 McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., et al. (in press). Risperidone for the core symptom domains of autism: Results from the RUPP Autism Network study. American Journal of Psychiatry. Minderaa, 1989, Neurochemical study of dopamine functioning in autistic and normal subjects, Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200 Minderaa, 1994, Noradrenergic and adrenergic functioning in autism, Biological Psychiatry, 36, 237, 10.1016/0006-3223(94)90605-X Modahl, 1998, Plasma oxytosin levels in autistic children, Biological Psychiatry, 43, 270, 10.1016/S0006-3223(97)00439-3 Moore, 1979, The locus coeruleus: Neurobiology of a central noradrenergic nucleus, Annual Review of Neuroscience, 2, 113, 10.1146/annurev.ne.02.030179.000553 Nagamitsu, 1993, CSF beta-endorphin levels in pediatric neurologic disorders, Kurume Medical Journal, 40, 233, 10.2739/kurumemedj.40.233 Nanson, 1992, Autism in fetal alcohol syndrome: A report of six cases, Alcohol Clinical Experimental Research, 16, 558, 10.1111/j.1530-0277.1992.tb01417.x Narayan, 1992, Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism, Biological Psychiatry, 33, 630, 10.1016/0006-3223(93)90102-J Niederhofer, 2002, Galantamine may be effective in treating autistic disorder, British Medical Journal, 325, 1422, 10.1136/bmj.325.7377.1422/a Panksepp, 1979, A neurochemical theory of autism, Trends in Neuroscience, 2, 174, 10.1016/0166-2236(79)90071-7 Pare, 1960, 5-Hydroxyindoles in mental deficiency, Journal of Neurology, Neurosurgery, and Psychiatry, 23, 341, 10.1136/jnnp.23.4.341 Partington, 1973, Blood serotonin levels in severe mental retardation, Developmental Medicine and Child Neurology, 15, 616, 10.1111/j.1469-8749.1973.tb05172.x Perry, 2001, Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain, American Journal of Psychiatry, 158, 1058, 10.1176/appi.ajp.158.7.1058 Persico, 2000, Lack of association between serotonin transporter gene promoter variants and autistic disroder in two ethnically distinct samples, American Journal of Medical Genetics, 96, 123, 10.1002/(SICI)1096-8628(20000207)96:1<123::AID-AJMG24>3.0.CO;2-N Raskind, 1984, Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease, Archives of General Psychiatry, 41, 343, 10.1001/archpsyc.1984.01790150033006 Raymond, 1996, Hippocampus in autism: A Golgi analysis, Acta Neuropathologica, 91, 117, 10.1007/s004010050401 Research Units on Pediatric Psychopharmacology Autism Network, 2002, Risperidone in children with autism and serious behavioral problems, The New England Journal of Medicine, 347, 314, 10.1056/NEJMoa013171 Ritvo, 1970, Increased blood serotonin and platelets in early infantile autism, Archives of General Psychiatry, 23, 566, 10.1001/archpsyc.1970.01750060086009 Roberts, 1978, Dopamine Ross, 1985, Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism, Annals of Neurology, 18, 394 Ross, 1987, Reduction of elevated CSF betaendorphin by fenfluramine in infantile autism, Pediatric Neurology, 3, 83, 10.1016/0887-8994(87)90032-4 Roy, 1988, Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine: Relationship to hypothalamic-pituitary-adrenal axis function in depression, Archives of General Psychiatry, 45, 849, 10.1001/archpsyc.1988.01800330081010 Sandman, 1988, Beta-endorphin dysregulation in autistic and self-injurious behavior: A neurodevelopmental hypothesis, Synapse, 2, 193, 10.1002/syn.890020304 Sandman, 1991, The opiate hypothesis in autism and self-injury, Journal of Child and Adolescent Psychopharmacology, 1, 237, 10.1089/cap.1990.1.237 Sandman, 1992, Various endogenous opioids and autistic behavior: A response to Gillberg, Journal of Autism and Developmental Disorders, 22, 132, 10.1007/BF01046410 Sandman, 1991, Plasma beta-endorphin and cortisol levels in autistic patients, Journal of Autism and Developmental Disorders, 21, 83, 10.1007/BF02207000 Schildkraut, 1978, Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions, Archives of General Psychiatry, 35, 1427, 10.1001/archpsyc.1978.01770360031003 Schroeder, 1988, Neuroleptic medications for persons with developmental disabilities, 82 Shain, 1961, Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children, Journal of Pediatrics, 58, 315, 10.1016/S0022-3476(61)80261-8 Simon, 1976, Some physical characteristics of a group of psychotic children, British Journal of Psychiatry, 110, 104, 10.1192/bjp.110.464.104 Sofroniew, 1981, Central nervous system distribution of vasopressin, oxytosin, and neurophysin, 327 Sponheim, 1998, Autism and related disorders: epidemiological findings in a Norwegian study using ICD-10 diagnostic criteria, Journal of Autism and Developmental Disorders, 28, 217, 10.1023/A:1026017405150 Stahl, 1996 Steffenberg, 1989, A twin study of autism in Denmark, Finland, Iceland, Norway, and Sweden, Journal of Child Psychology and Psychiatry, 30, 405, 10.1111/j.1469-7610.1989.tb00254.x Stokes, 1987, Hypothalamic-pituitary-adrenal axis in affective disorders Szatmari, 1991, IQ and the genetics of autism, Journal of Child Psychology and Psychiatry, 35, 215 Takahashi, 1976, Reassessment of elevated serotonin levels in blood platelets in early infantile autism, Journal of Autism and Childhood Schizophrenia, 6, 317, 10.1007/BF01537909 Tordjman, 1997, Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism, Journal of Child Psychology and Psychiatry, 38, 705, 10.1111/j.1469-7610.1997.tb01697.x Tordjman, 2001, Role of the serotonin transporter gene in the behavioral expression of autism, Molecular Psychiatry, 6, 434, 10.1038/sj.mp.4000873 Trottier, 1999, Etiology of infantile autism: a review of recent advances in genetic and neurobiological research, Journal of Psychiatry and Neuroscience, 24, 103 Volkmar, 2001, Pharmacological interventions in autism: theoretical and practical issues, Journal of Clinical Child Psychology, 30, 80, 10.1207/S15374424JCCP3001_9 Volkmar, 1998, Diagnosis and definition of autism and other pervasive developmental disorders, 1 Weizman, 1988, Low plasma immunoreactive beta-endorphin levels in autistics, Journal of the American Academy of Child and Adolescent Psychiatry, 27, 430, 10.1097/00004583-198807000-00009 Weizman, 1984, Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects, Psychopharmacology (Berlin), 82, 368, 10.1007/BF00427687 Werry, 1999, Anxiolytics, sedatives, and miscellaneous drugs, 433 Whitaker-Azimitia, 2001, Serotonin and brain development: Role in human developmental diseases, Brain Research Bulletin, 56, 479, 10.1016/S0361-9230(01)00615-3 Willemsen-Swinkles, 1996, Plasma beta-endorphin concentrations in people with learning disabilities and self-injurious and/or autistic behavior, British Journal of Psychiatry, 168, 105, 10.1192/bjp.168.1.105 Winsberg, 1980, Estimation of monoamine and cyclic AMP turnover and amino acid concentration of spinal fluid in autistic children, Neuroleptics, 11, 250 World Health Organization, 1994 Yamazaki, 1975, An application of neuroendocrinological studies in autistic children and Heller's syndrome, Journal of Autism and Childhood Schizophrenia, 5, 323, 10.1007/BF01540679 Yirmiya, 2001, Evidence for an association with the serotonin transporter region polymorphism and autism, American Journal of Medical Genetics, 105, 381, 10.1002/ajmg.1365 Young, 1978, Decreased urinary free catecholamines in childhood autism, Journal of the American Academy of Child and Adolescent Psychiatry, 17, 671, 10.1016/S0002-7138(09)61019-0 Young, 1981, Cerebrospinal fluid, plasma, and urinary MHPG in children, Life Sciences, 28, 2837, 10.1016/0024-3205(81)90099-0 Young, 1982, Clinical neurochemistry of autism and related disorders, Journal of Autism and Developmental Disorders, 12, 147, 10.1007/BF01531305 Ziegler, 1977, Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid, American Journal of Psychiatry, 134, 565, 10.1176/ajp.134.5.565